Market Watch – Page 526 – Biotech Insider

All Posts in "Market Watch"

Intel’s manufacturing issues continue, and could help rival AMD

Investors remain nonplussed by supply problems since guidance remains on track

by Editor — November 22, 2019 By Editor in Market Watch

Dow, S&P 500 close lower for third consecutive day amid anxiety over trade

Ameritrade surges 20% on report of potential acquisition by Schwab

by Editor — November 22, 2019 By Editor in Market Watch

Walmart earnings preview: Battle with Amazon for grocery delivery dominance heats up

Walmart may rethink its grocery delivery program now that Amazon has eliminated the fee for Prime members

by Editor — November 14, 2019 By Editor in Market Watch

Shares of Yahoo Japan’s parent soar on acquisition talks with Line

SoftBank could emerge as the big winner

by Editor — November 14, 2019 By Editor in Market Watch

Asian markets mixed after weaker economic data from China, Japan

Nikkei, Hang Seng retreat while stocks in mainland China inch up

by Editor — November 14, 2019 By Editor in Market Watch

Cisco confirms fears of a ‘broad-based’ slowdown in tech spending

Large enterprises sending expenditures through more processes and sometimes downsizing deals, Cisco executives say, as stock falls in late trading

by Editor — November 14, 2019 By Editor in Market Watch

Oil futures rise, looking to recoup losses from back-to-back declines

Oil demand seen waning after 2025, IEA says

by Editor — November 13, 2019 By Editor in Market Watch

Asian markets fall as Trump threatens more tariff hikes on China

Nikkei, Hang Seng lead regional declines

by Editor — November 13, 2019 By Editor in Market Watch

European stocks drop amid disappointment over Trump trade comments

ABN Amro, autos, banks among the losing stocks

by Editor — November 13, 2019 By Editor in Market Watch

Stocks slightly lower as rally pauses on concerns about trade and interest rates

U.S. consumer prices up 1.8% for year

by Editor — November 13, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.